Close Menu

NEW YORK (GenomeWeb) – Roche said today that its diagnostics division revenues grew 6 percent in the first nine months of 2018, driven mainly by growing demand for its immunodiagnostics solutions. 

For the nine months ended Sept. 30, the Basel, Switzerland-based pharmaceuticals and diagnostics giant's total revenues rose 7 percent to CHF 42.08 billion ($42.42 billion) from CHF 39.43 billion during the same period in 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.